Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoption of the Xo-Motion R in the Subacute and Chronic SCI Populations at the Glenrose Rehabilitation Hospital

NCT07380516 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT07380516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07380516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoption of the Xo-Motion R in the Subacute and Chronic SCI Populations at the Glenrose Rehabilitation Hospital
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
September 30, 2028
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury